BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 2628582)

  • 21. Response of T lymphocytes to phytohaemagglutinin (PHA) and to cancer-tissue-associated antigens, measured by the intracellular fluorescence polarization technique (SCM test).
    Orjasaeter H; Jordfald G; Svendsen I
    Br J Cancer; 1979 Oct; 40(4):628-33. PubMed ID: 387060
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of cellular fluidity of peripheral blood lymphocytes from patients with urogenital cancers by a fluorescence polarization technique: PHA response and prognosis.
    Sakamoto S; Maeda H; Yamasaki K; Aikawa S; Hinuma Y
    Eur J Cancer Clin Oncol; 1981 Oct; 17(10):1105-15. PubMed ID: 7200019
    [No Abstract]   [Full Text] [Related]  

  • 23. Flow cytofluorimetry of fluorescein fluorescence polarization to assay lymphocyte activation.
    Dimitropoulos K; Rolland JM; Nairn RC
    Biochem Biophys Res Commun; 1986 May; 136(3):1021-9. PubMed ID: 2424436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The trace and subgrouping of lymphocyte activation by dynamic fluorescence intensity and polarization measurements.
    Sunray M; Kaufman M; Zurgil N; Deutsch M
    Biochem Biophys Res Commun; 1999 Aug; 261(3):712-9. PubMed ID: 10441491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intracellular binding of fluorescein in lymphocytes.
    Meisingset KK; Steen HB
    Cytometry; 1981 Jan; 1(4):272-8. PubMed ID: 7261813
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A diagnostic assay for the Wiskott-Aldrich syndrome and its variant forms.
    Siminovitch KA; Greer WL; Novogrodsky A; Axelsson B; Somani AK; Peacocke M
    J Investig Med; 1995 Apr; 43(2):159-69. PubMed ID: 7735919
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluorescent probes to detect lymphocyte activation.
    Nairn RC; Rolland JM
    Clin Exp Immunol; 1980 Jan; 39(1):1-13. PubMed ID: 6156040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of daunorubicin on membrane permeability properties: detection by means of intracellular accumulation and efflux of fluorescein.
    Prosperi E; Croce AC; Bottiroli G; Supino R
    Chem Biol Interact; 1985; 54(3):271-80. PubMed ID: 4053216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flow cytometric analysis of membrane permeability properties influencing intracellular accumulation and efflux of fluorescein.
    Prosperi E; Croce AC; Bottiroli G; Supino R
    Cytometry; 1986 Jan; 7(1):70-5. PubMed ID: 3948603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flow cytometric measurement of the polarization of fluorescence from intracellular fluorescein in mammalian cells.
    Lindmo T; Steen HB
    Biophys J; 1977 May; 18(2):173-87. PubMed ID: 140713
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intracellular turnover of fluorescein diacetate. Influence of membrane ionic gradients on fluorescein efflux.
    Prosperi E
    Histochem J; 1990 Apr; 22(4):227-33. PubMed ID: 2387757
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Lymphocyte membrane study with fluorescent probes (a review of the literature)].
    Baglaev TN
    Lab Delo; 1986; (7):387-92. PubMed ID: 2429023
    [No Abstract]   [Full Text] [Related]  

  • 33. WASp in immune-system organization and function.
    Thrasher AJ
    Nat Rev Immunol; 2002 Sep; 2(9):635-46. PubMed ID: 12209132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polar fluorescein derivatives as improved substrate probes for flow cytoenzymological assay of cellular esterases.
    Dive C; Cox H; Watson JV; Workman P
    Mol Cell Probes; 1988 Jun; 2(2):131-45. PubMed ID: 3173358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. X-linked thrombocytopenia and thrombocytopathia: attenuated Wiskott-Aldrich syndrome. Functional and morphological studies of platelets and lymphocytes.
    Stormorken H; Hellum B; Egeland T; Abrahamsen TG; Hovig T
    Thromb Haemost; 1991 Mar; 65(3):300-5. PubMed ID: 2048054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Determination of cellular thiol levels in individual viable lymphocytes by means of fluorescence intensity and polarization.
    Zurgil N; Kaufman M; Solodiev I; Deutsch M
    J Immunol Methods; 1999 Oct; 229(1-2):23-34. PubMed ID: 10556688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fluorescence polarization with FDA in leukaemic cells: a clear difference between myelogenous and lymphocytic origins.
    Tsuda H; Maeda H; Kishimoto S
    Br J Cancer; 1981 Jun; 43(6):793-803. PubMed ID: 6941807
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fluorescent lymphocyte probes for cancer detection.
    Rolland JM; Hocking GR; Nairn RC
    Ann N Y Acad Sci; 1983; 420():215-8. PubMed ID: 6586094
    [No Abstract]   [Full Text] [Related]  

  • 39. Update of the Wiskott-Aldrich syndrome. From a new case report.
    Martín Mateos MA; Muñoz-López F; Cruz M
    Allergol Immunopathol (Madr); 1988; 16(2):113-9. PubMed ID: 3394592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indication that intracellular fluorescence polarization of T lymphocytes is cell cycle dependent.
    Zurgil N; Deutsch M; Tirosh R; Brodie C
    Cell Struct Funct; 1996 Aug; 21(4):271-6. PubMed ID: 8906363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.